In Vitro ADME Market

The study on the In vitro adme market offers insights, information, and recommendation to market stakeholders and investors to help them prioritize and formulate strategic decisions. The report includes In vitro adme market across more than 15 countries. The study is analyzed on the basis of rigorous research methodology, which covers extensive desk research using qualitative analysis, quantitative/statistical methods, and primary interviews.

The study analyzes the market scope, revenue size, and growth of the global In vitro adme market and monitors the prime trends at the regional level. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. The report includes a section on the company profile that covers the company overview, company snapshot, key executives, product/service portfolio, operating business segments, business performance, R&D expenditure, and key strategic moves & developments. The global In vitro adme market is categorized on the basis of by drug metabolism assay kits, by drug transporter assays, by drug metabolism services, by pharmacokinetic (pk) testing services, by perfusion systems, by 3d cell culture systems. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Spain, Italy, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Key players covered in this report are Thermo Fisher Scientific, Merck and Co., Inc., Eurofins Scientific, Charles River Laboratories, BioIVT, SGS SA, General Electric, Laboratory Corporation of America, Danaher Corporation, Covance, Inc.

Deliverables:

Market size value forecast by country
Regional-level market trends and market dynamics
Porter’s five forces model and PESTLE Analysis
Company profile, competition landscape inclusive of heatmap analysis, competition dashboard and product/service offerings
Major developmental strategies and M&A activities
Country-wise market size and forecast for each segment
Market share of leading players worldwide

Market Taxonomy

This report divides the global In vitro adme market on the basis of by drug metabolism assay kits, by drug transporter assays, by drug metabolism services, by pharmacokinetic (pk) testing services, by perfusion systems, by 3d cell culture systems. On the basis of region, the global In vitro adme market analyzed across North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa.

In Vitro ADME Market Report Highlights

Aspects	Details
By Drug Metabolism Assay Kits	Cytochrome P450 (CYP) Assays Paracellular Permeability Assay Kits Intestinal Permeability Assay Kits
By Drug Transporter Assays	Uptake Transporter Assays Efflux Transporter Assays Inhibition Transporter Assays
By Drug Metabolism Services	Metabolite Identification Services Drug-Drug Interaction Services In Vitro Metabolism and Pharmacokinetic Services
By Pharmacokinetic (PK) Testing Services	Bioavailability and Bioequivalence Testing Services Stability Testing Services In Vitro Biopharmaceutical Screening Services
By Perfusion Systems	Cell Culture Perfusion Systems Microfluidics-based Perfusion Systems Organ-Chip Perfusion Systems
By 3D Cell Culture Systems	Scaffold-based Culture Systems Scaffold-free Culture Systems 3D Bioprinting Systems
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Charles River Laboratories, Covance, SGS SA, BioIVT, Eurofins Scientific, Danaher Corporation, Thermo Fisher Scientific, Merck and Co., General Electric, Laboratory Corporation of America

Loading Table Of Content...